Volume 66, Issue 6, Pages (December 2004)

Slides:

Advertisements

Similar presentations

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Advertisements

Central venous catheter outcomes in nocturnal hemodialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Hemoglobin, EPO, & Iron dose figure 4

Anemia management in chronic kidney disease

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Volume 64, Pages S3-S12 (December 2003)

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Volume 75, Issue 11, Pages (June 2009)

Type of vascular access and mortality in U.S. hemodialysis patients

Volume 56, Issue 2, Pages (August 1999)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Volume 70, Pages S21-S25 (December 2006)

Volume 61, Issue 3, Pages (March 2002)

Volume 63, Issue 2, Pages (February 2003)

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 77, Issue 2, Pages (January 2010)

Nephrology Crosswords: Hemodialysis

The epidemiology of chronic kidney disease

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Body size and outcomes on peritoneal dialysis in the United States

Volume 70, Issue 12, Pages (December 2006)

Relationship between methylmalonic acid and cobalamin in uremia

Blood pressure targets in hemodialysis patients

Locking of tunneled hemodialysis catheters with gentamicin and heparin

Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? Areef Ishani, Charles A. Herzog,

Recent experience with high-dose intravenous iron administration

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 79, Issue 3, Pages (February 2011)

Microbiology and outcomes of peritonitis in North America

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

The global challenge of chronic kidney disease

Reviewer Acknowledgment

Hemoglobin variability in epoetin-treated hemodialysis patients

Daily nocturnal home hemodialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu Kidney International

Current status of maintenance hemodialysis in Beijing, China

Phosphate binders on iron basis: A new perspective?

Volume 61, Issue 1, Pages (January 2002)

Volume 70, Issue 8, Pages (October 2006)

Volume 63, Issue 3, Pages (March 2003)

Volume 64, Issue 5, Pages (November 2003)

Volume 60, Issue 6, Pages (December 2001)

Volume 58, Issue 6, Pages (December 2000)

Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson

Volume 62, Issue 6, Pages (December 2002)

Volume 86, Issue 2, Pages (August 2014)

Volume 70, Issue 5, Pages (September 2006)

H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae Kidney International

Strategies for iron supplementation: Oral versus intravenous

The International Pediatric Peritonitis Registry: Starting to walk

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Hemodialysis access failure: a call to action—revisited

Ivan D. Maya, Michael Allon Kidney International

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Central venous catheter outcomes in nocturnal hemodialysis

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Volume 66, Issue 6, Pages 2429-2436 (December 2004) Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients Tricia L. Roberts, Gregorio T. Obrador, Wendy L. St. Peter, Brian J.G. Pereira, Allan J. Collins Kidney International Volume 66, Issue 6, Pages 2429-2436 (December 2004) DOI: 10.1111/j.1523-1755.2004.66020.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Mean hemoglobin (A), mean rHuEPO dose/wk (B), and mean monthly vials of IV iron (C) by number of catheter insertions (temporary or permanent) and hospitalizations for vascular access (VA) infection during 2000. Includes prevalent rHuEPO-treated hemodialysis patients in 2000. Kidney International 2004 66, 2429-2436DOI: (10.1111/j.1523-1755.2004.66020.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Mean hemoglobin (A), mean rHuEPO dose/wk (B), and mean number of months with IV iron during 6-month follow-up (C), by number of entry-period catheter insertions (temporary or permanent) and hospitalizations for vascular access (VA) infection. Includes 1997 to 1999 incident rHuEPO-treated hemodialysis patients. Kidney International 2004 66, 2429-2436DOI: (10.1111/j.1523-1755.2004.66020.x) Copyright © 2004 International Society of Nephrology Terms and Conditions